| Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy SJ Priceman, JL Sung, Z Shaposhnik, JB Burton, AX Torres-Collado, ... Blood, The Journal of the American Society of Hematology 115 (7), 1461-1471, 2010 | 412 | 2010 |
| Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy W Fan, Z Tang, D Chen, D Moughon, X Ding, S Chen, M Zhu, Q Zhong Autophagy 6 (5), 614-621, 2010 | 254 | 2010 |
| CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy J Escamilla, S Schokrpur, C Liu, SJ Priceman, D Moughon, Z Jiang, ... Cancer research 75 (6), 950-962, 2015 | 192 | 2015 |
| Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma JP Antonios, H Soto, RG Everson, D Moughon, JR Orpilla, NP Shin, ... Neuro-oncology 19 (6), 796-807, 2017 | 188 | 2017 |
| PD-1 blockade enhances the vaccination-induced immune response in glioma JP Antonios, H Soto, RG Everson, J Orpilla, D Moughon, N Shin, ... JCI insight 1 (10), 2016 | 141 | 2016 |
| Macrophage blockade using CSF1R inhibitors reverses the vascular leakage underlying malignant ascites in late-stage epithelial ovarian cancer DL Moughon, H He, S Schokrpur, ZK Jiang, M Yaqoob, J David, C Lin, ... Cancer research 75 (22), 4742-4752, 2015 | 116 | 2015 |
| Detection of immune responses after immunotherapy in glioblastoma using PET and MRI JP Antonios, H Soto, RG Everson, DL Moughon, AC Wang, J Orpilla, ... Proceedings of the National Academy of Sciences 114 (38), 10220-10225, 2017 | 94 | 2017 |
| CRISPR-mediated VHL knockout generates an improved model for metastatic renal cell carcinoma S Schokrpur, J Hu, DL Moughon, P Liu, LC Lin, K Hermann, S Mangul, ... Scientific reports 6 (1), 29032, 2016 | 61 | 2016 |
| Rapamycin enhances adenovirus-mediated cancer imaging and therapy in pre-immunized murine hosts ZK Jiang, M Johnson, DL Moughon, J Kuo, M Sato, L Wu PLoS One 8 (9), e73650, 2013 | 9 | 2013 |
| Atim-39. Improved survival noted in glioblastoma patients treated with adjuvant tlr-3 agonist in setting of autologous lysate-pulsed dc vaccination J Antonios, R Everson, H Soto, S Khattab, J Bethel, M Sun, A Mochizuki, ... Neuro-oncology 20 (Suppl 6), vi10, 2018 | 2 | 2018 |
| ATIM-26. PD-1 expression by tumor infiltrating lymphocytes in glioblastoma is a marker of both activation and exhaustion MINRCNS LYMPHOMA Neuro-Oncology, 2016 | 1 | 2016 |
| Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial JP Antonios, R Everson, A Mochizuki, S Khattab, P Romiyo, M Sun, ... JOURNAL OF NEUROSURGERY 132 (4), 83-83, 2020 | | 2020 |
| Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic cell vaccination. JP Antonios, RG Everson, A Mochizuki, S Khattab, H Soto, P Romiyo, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 30-30, 2020 | | 2020 |
| PR13 Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic cell … JP Antonios, RG Everson, A Mochizuki, S Khattab, H Soto, P Romiyo, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 99-99, 2020 | | 2020 |
| Abstract PR13: Adjuvant TLR-3 administration enhances proinflammatory immune responses and is associated with extended survival in glioblastoma patients treated with dendritic … JP Antonios, RG Everson, A Mochizuki, S Khattab, H Soto, P Romiyo, ... Cancer Immunology Research 8 (3_Supplement), PR13-PR13, 2020 | | 2020 |
| NIMG-36. DELINEATION OF IMMUNE RESPONSES AFTER IMMUNOTHERAPY IN GLIOBLASTOMA USING PET AND MRI H Soto, J Antonios, R Everson, D Moughon, A Wang, J Orpilla, C Radu, ... Neuro-oncology 19 (Suppl 6), vi149, 2017 | | 2017 |
| SUBTYPE-SPECIFIC CELLULAR COMPOSITION OF THE GLIOBLASTOMA MICROENVIRONMENT J Antonios, H Soto, R Everson, J Orpilla, N Shin, D Moughon, S Sedighim, ... NEURO-ONCOLOGY 18, 203-203, 2016 | | 2016 |
| Phase IIa clinical trial evaluating dendritic cell vaccine for the treatment of low-grade gliomas D Moughon, R Everson, S Odesa, H Soto, E Billingslea-Yoon, S Sedighim, ... Neuro-Oncology 18, 25-25, 2016 | | 2016 |
| TMIC-18. ROLE OF MICROGLIA IN THE EARLY STEPS OF THE BRAIN METASTATIC CASCADE A Berghoff, M Feinauer, G Solecki, J Grosch, M Osswald, B Gil, D Wilhelm, ... Neuro-Oncology 18 (suppl_6), vi203-vi204, 2016 | | 2016 |
| Colony-Stimulating Factor-1 Receptor Inhibition Reverses the Vascular Leakage that Causes DL Moughon | | 2015 |
